"","KE ID","AOP ID","Molecular Pathways"
"1","Accumulation Acetylcholine In Synapses","Acetylcholinesterase inhibition leading to acute mortality","SYNAPSES"
"2","Stabilization Ppar Alpha Co-Repressor","Antagonist binding to PPARÎ± leading to body-weight loss","GO:0003714"
"3","Increased Developmental Defects","Disruption of VEGFR Signaling Leading to Developmental Defects","GO:0009653"
"4","Inhibition Deiodinase 2","Deiodinase 2 inhibition leading to increased mortality via reduced posterior swim bladder inflation","GO:0003824"
"5","Decreased Triiodothyronine T3 In Serum","Deiodinase 2 inhibition leading to increased mortality via reduced posterior swim bladder inflation","HUMAN THYROID STIMULATING HORMONE TSH SIGNALING PATHWAY"
"6","Reduced Posterior Swim Bladder Inflation","Deiodinase 2 inhibition leading to increased mortality via reduced posterior swim bladder inflation","ABNORMALITY OF THE BLADDER"
"7","Reduced Swimming Performance","Deiodinase 2 inhibition leading to increased mortality via reduced posterior swim bladder inflation","LOCOMOTORY BEHAVIOR"
"8","Reduced Anterior Swim Bladder Inflation","Deiodinase 2 inhibition leading to increased mortality via reduced anterior swim bladder inflation","ABNORMALITY OF THE BLADDER"
"9","Reduced Hearing","GSK3beta inactivation leading to increased mortality via defects in developing inner ear","PROGRESSIVE HEARING IMPAIRMENT"
"10","Inhibition Deiodinase 1","Deiodinase 1 inhibition leading to increased mortality via reduced posterior swim bladder inflation","GO:0003824"
"11","Increased Inhibitory Postsynaptic Potential","Ionotropic gamma-aminobutyric acid receptor activation mediated neurotransmission inhibition leading to mortality","GO:0060080"
"12","Induction Somatic Muscle Paralysis","Ionotropic gamma-aminobutyric acid receptor activation mediated neurotransmission inhibition leading to mortality","PARALYSIS"
"13","Increased Neuronal Synaptic Inhibition","Glutamate-gated chloride channel activation leading to neurotransmission inhibition associated mortality","GO:0050805"
"14","Inhibition Feeding","Glutamate-gated chloride channel activation leading to neurotransmission inhibition associated mortality","TUBE FEEDING"
"15","Activation Glutamate-Gated Chloride Channels","Glutamate-gated chloride channel activation leading to neurotransmission inhibition associated mortality","GO:0005254"
"16","Induction Pharyngeal Muscle Paralysis","Glutamate-gated chloride channel activation leading to neurotransmission inhibition associated mortality","PARALYSIS"
"17","Increased Thyroid-Stimulating Hormone Tsh","Enhanced hepatic clearance of thyroid hormones leading to thyroid follicular cell adenomas and carcinomas in the rat and mouse","HUMAN THYROID STIMULATING HORMONE TSH SIGNALING PATHWAY"
"18","Activation Of Specific Nuclear Receptors Ppar-Gamma Activation","PPARgamma activation leading to sarcomas in rats, mice, and hamsters","GO:0035357"
"19","Increased Secretion Of Local Growth Factors","PPARgamma activation leading to sarcomas in rats, mice, and hamsters","GO:0046903"
"20","Increased Proliferation Of Mesenchymal Cells","PPARgamma activation leading to sarcomas in rats, mice, and hamsters","GO:0010463"
"21","Increased Igf-1 Mouse","PPARgamma activation leading to sarcomas in rats, mice, and hamsters","CTOME SIGNALING BY TYPE 1 INSULIN LIKE GROWTH FACTOR 1 RECEPTOR IGF1R"
"22","Activation Beta-2 Adrenergic Receptor","Beta-2 adrenergic agonist activity leading to mesovarian leiomyomas in the rat and mouse","ADRENERGIC RECEPTOR SIGNALING PATHWAY"
"23","Increased Activity Beta-2 Adrenergic Receptor","Beta-2 adrenergic agonist activity leading to mesovarian leiomyomas in the rat and mouse","ADRENERGIC RECEPTOR SIGNALING PATHWAY"
"24","Relaxation Smooth Muscle","Beta-2 adrenergic agonist activity leading to mesovarian leiomyomas in the rat and mouse","GO:0044557"
"25","Proliferation/Clonal Expansion Smooth Muscle","Beta-2 adrenergic agonist activity leading to mesovarian leiomyomas in the rat and mouse","GO:0008283"
"26","Hypertrophy/Hyperplasia Smooth Muscle","Beta-2 adrenergic agonist activity leading to mesovarian leiomyomas in the rat and mouse","SMOOTH MUSCLE CELL PROLIFERATION"
"27","Decreased Ovarian E2","Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse","ABNORMAL OVARIAN MORPHOLOGY"
"28","Suppression Estrogen Receptor Er Activity","Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse","GO:0030284"
"29","Increased Secretion Of Gnrh From Hypothalamus","Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse","GO:0046879"
"30","Increased Secrection Of Fsh From Anterior Pituitary","Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse","GO:0046884"
"31","Increased Secretion Of Lh From Anterior Pituitary","Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse","ANTERIOR PITUITARY AGENESIS"
"32","Hyperplasia Ovarian Stromal Cells","Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse","ADRENAL HYPERPLASIA"
"33","Promotion Ovarian Adenomas","Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse","ABNORMAL OVARIAN MORPHOLOGY"
"34","Promotion Ovarian Granular Cell Tumors","Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse","ABNORMAL OVARIAN MORPHOLOGY"
"35","Decrease E2 Blood Concentrations At Hypothalamus","Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse","ABNORMAL HYPOTHALAMUS PHYSIOLOGY"
"36","Increased Ppar-Alpha Activation","PPARalpha activation leading to pancreatic acinar tumors in the rat and mouse","GO:0035357"
"37","Decreased Bile Flow","PPARalpha activation leading to pancreatic acinar tumors in the rat and mouse","DRUG INDUCTION OF BILE ACID PATHWAY"
"38","Increased Cholestasis","PPARalpha activation leading to pancreatic acinar tumors in the rat and mouse","CHOLESTASIS"
"39","Alteration Lipid Metabolism","PPARalpha activation leading to pancreatic acinar tumors in the rat and mouse","GO:0006629"
"40","Increased Cellular Proliferation / Hyperplasia Of Acinar Cells","PPARalpha activation leading to pancreatic acinar tumors in the rat and mouse","GO:0008283"
"41","Increased Pancreatic Acinar Tumors","PPARalpha activation leading to pancreatic acinar tumors in the rat and mouse","PANCREATIC HYPOPLASIA"
"42","Activation Estrogen Receptor Alpha","Early-life estrogen receptor activity leading to endometrial carcinoma in the mouse.","GO:0030520"
"43","Proliferation/Clonal Expansion Aberrant Basal Cells","Early-life estrogen receptor activity leading to endometrial carcinoma in the mouse.","GO:0008283"
"44","Squamous Metaplasia Aberrant Basal Cells","Early-life estrogen receptor activity leading to endometrial carcinoma in the mouse.","SQUAMOUS CELL CARCINOMA"
"45","Increased Hyperplasia Glandular Epithelial Cells Of Endometrium","Early-life estrogen receptor activity leading to endometrial carcinoma in the mouse.","ABNORMALITY OF THE ENDOMETRIUM"
"46","Increased Adenosquamous Carcinomas Of Endometrium","Early-life estrogen receptor activity leading to endometrial carcinoma in the mouse.","ABNORMALITY OF THE ENDOMETRIUM"
"47","Decreased Gnrh Pulsatility/Release In Hypothalamus","GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat.","GO:0046879"
"48","Decreased Lh Surge From Anterior Pituitary","GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat.","GO:0046879"
"49","Interruption Ovulation","GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat.","OVULATION"
"50","Prolonged Estrus","GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat.","PROLONGED NEONATAL JAUNDICE"
"51","Increased Circulating Estrogen Levels","GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat.","ABNORMAL CIRCULATING ESTROGEN LEVEL"
"52","Increased Prolactin Exposure","GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat.","INCREASED CIRCULATING PROLACTIN CONCENTRATION"
"53","Increased Lactotroph Hyperplasia And Hypertrophy","GnRH pulse disruption leading to pituitary adenomas and carcinomas in the SD rat.","ADRENAL HYPERPLASIA"
"54","Increased Adenomas Pituitary","GnRH pulse disruption leading to pituitary adenomas and carcinomas in the SD rat.","ABNORMALITY OF THE PITUITARY GLAND"
"55","Decreased Dopaminergic Activity","Anti-dopaminergic activity leading to mammary adenomas and carcinomas in the SD rat","GO:0001963"
"56","Increased Prolactin Secretion","Anti-dopaminergic activity leading to mammary adenomas and carcinomas in the SD rat","INCREASED CIRCULATING PROLACTIN CONCENTRATION"
"57","Persistent Cytotoxicity Pleura Or Peritoneum","Chronic cytotoxicity of the serous membrane leading to pleural/peritoneal mesotheliomas in the rat.","ABNORMAL PLEURA MORPHOLOGY"
"58","Increased Inflammation","Chronic cytotoxicity of the serous membrane leading to pleural/peritoneal mesotheliomas in the rat.","GO:0006954"
"59","Increased Cell Proliferation Mesothelium","Chronic cytotoxicity of the serous membrane leading to pleural/peritoneal mesotheliomas in the rat.","GO:0008283"
"60","Increased Blood Uric Acid Concentration","Organic anion transporter (OAT1) inhibition leading to renal failure and mortality","INCREASED LEVEL OF HIPPURIC ACID IN URINE"
"61","Occurrence Renal Proximal Tubular Necrosis","Organic anion transporter (OAT1) inhibition leading to renal failure and mortality","RENAL TUBULAR DYSFUNCTION"
"62","Increased Blood Potassium Concentration","Organic anion transporter (OAT1) inhibition leading to renal failure and mortality","ABNORMAL BLOOD POTASSIUM CONCENTRATION"
"63","Impairment Endothelial Network","Disruption of VEGFR Signaling Leading to Developmental Defects","GO:0003158"
"64","Inhibition Cyclooxygenase 1 Activity","Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality","GO:0004666"
"65","Decreased Prostaglandin F2alpha Concentration Plasma","Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality","DECREASED PLASMA CARNITINE"
"66","Occurrence Renal Ischemia","Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality","TISSUE ISCHEMIA"
"67","Occurrence Cardiac Arrhythmia","Cyclooxygenase 1 (COX1) inhibition leading to renal failure and mortality","VENTRICULAR ARRHYTHMIA"
"68","Increased Deformed Wing Virus Levels","Varroa mite infestation increases virus levels leading to colony loss/failure","ABNORMALITY OF THE WING OF THE ILIUM"
"69","Agonism Estrogen Receptor","Estrogen receptor agonism leading to reproductive dysfunction","GO:0030284"
"70","Increased Energetic Demands And Therefore Metabolic Stress","Nosema infection increases energetic demands leading to colony loss/failure","OXIDATIVE STRESS"
"71","Decreased Triiodothyronine T3 In Tissues","Type I iodothyronine deiodinase (DIO1) inhibition leading to altered amphibian metamorphosis","ABNORMAL THYROID HORMONE LEVEL"
"72","Antagonism Estrogen Receptor","Estrogen receptor antagonism leading to reproductive dysfunction","GO:0030284"
"73","Failure In Vascular Repair Mechanisms Unresolved Blood Loss Hemorrhage","Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage","GO:0042060"
"74","Hemostasis Depletion From Blood Of Fully Functional Carboxylated Clotting Factors","Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage","BLOOD CLOTTING CASCADE"
"75","Reduced Fitness Or Even Mortality Acidosis Hypovolemic Shock And Organ Dysfunction","Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage","MORTALITY AGING"
"76","Increase Fa Influx","LXR activation leading to hepatic steatosis","GO:2000193"
"77","Osteoporosis And Vascular Calcification Bone Deterioration","Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage","VASCULAR CALCIFICATION"
"78","Inhibition Iodotyrosine Deiodinase Iyd","Iodotyrosine deiodinase (IYD) inhibition leading to altered amphibian metamorphosis","GO:0003824"
"79","Inhibition Deiodinase 3","Type III iodotyrosine deiodinase (DIO3) inhibition leading to altered amphibian metamorphosis","GO:0003824"
"80","Increased Triiodothyronine T3 In Tissues","Type III iodotyrosine deiodinase (DIO3) inhibition leading to altered amphibian metamorphosis","ABNORMAL THYROID HORMONE LEVEL"
"81","Inhibition Dual Oxidase","Dual oxidase (DUOX) inhibition leading to altered amphibian metamorphosis","GO:0003824"
"82","Activation Hepatic Nuclear Receptors","Hepatic nuclear receptor activation leading to altered amphibian metamorphosis","NUCLEAR RECEPTORS"
"83","Increased Hepatic Thyroid Hormone Uptake/Transport","Hepatic nuclear receptor activation leading to altered amphibian metamorphosis","ABNORMAL THYROID HORMONE LEVEL"
"84","Activation Fas","LXR activation leading to hepatic steatosis","FAS LIGAND FASL PATHWAY AND STRESS INDUCTION OF HEAT SHOCK PROTEINS HSP REGULATION"
"85","Increased Oocyte Maturation","5-hydroxytryptamine transporter (5-HTT) inhibition leading to population increase","GO:0048469"
"86","Increased Reproductive Success","5-hydroxytryptamine transporter inhibition leading to increased reproductive success and population increase","GO:0022414"
"87","Activation Nadph Oxidase","NADPH oxidase and P38 MAPK activation leading to reproductive failure in Caenorhabditis elegans","CTOME RHO GTPASES ACTIVATE NADPH OXIDASES"
"88","Decreased Sodium Conductance 2","Sodium channel (Nav1.1) inhibition leading to population decline","ABNORMAL BLOOD SODIUM CONCENTRATION"
"89","Decreased Gaba Release","Sodium channel (Nav1.1) inhibition leading to population decline","DECREASED LEVEL OF GABA IN SERUM"
"90","Formation Formation Of Hemoglobin Adducts","Oxidation of iron in hemoglobin leading to hematotoxicity","GO:0042541"
"91","Increase Cell Proliferation Epithelial Cells","Estrogen receptor activation leading to breast cancer","GO:0008283"
"92","Decreased Apoptosis Epithelial Cells","Estrogen receptor activation leading to breast cancer","GO:0006915"
"93","Increased Er Binding To Dna Classical Pathway","Estrogen receptor activation leading to breast cancer","GO:0030331"
"94","Increased Er Binding To Tf To Dna Non-Classical Pathway","Estrogen receptor activation leading to breast cancer","GO:0030331"
"95","Increased Proliferation Endothelial Cells","Estrogen receptor activation leading to breast cancer","GO:0001935"
"96","N/A Gap","Cyclooxygenase inhibition leading reproductive failure","SANDAL GAP"
"97","Increased Migration Endothelial Cells","Estrogen receptor activation leading to breast cancer","GO:0043542"
"98","Increased Non-Genomic Signaling","Estrogen receptor activation leading to breast cancer","INCREASED HEMOGLOBIN"
"99","N/A Breast Cancer","Estrogen receptor activation leading to breast cancer","BREAST CANCER PATHWAY"
"100","Increased Invasion","Estrogen receptor activation leading to breast cancer","CELL MIGRATION AND INVASION THROUGH P75NTR"
"101","Inhibition Acetylcholinesterase Ache","Acetylcholinesterase inhibition leading to acute mortality","INHIBITION ACETYLCHOLINESTERASE ACHE"
"102","Suppression Il-2 And Il-4 Production","Inhibition of Calcineurin Activity Leading to Impaired T-Cell Dependent Antibody Response","GO:0032623"
"103","Induction Male Reproductive Tract","Juvenile hormone receptor agonism leading to male offspring induction associated population decline","MALE REPRODUCTIVE SYSTEM NEOPLASM"
"104","Increased Angiogenesis","Estrogen receptor activation leading to breast cancer","GO:0001525"
"105","Opening Of Calcium Channel Calcium Influx","Volatile Organic Chemicals Activate TRPA1 Receptor to Induce Sensory Pulmonary Irritation","GO:0006816"
"106","Activation Glucocorticoid Receptor","Glucocorticoid Receptor Activation Leading to Increased Disease Susceptibility","GLUCOCORTICOID RECEPTOR PATHWAY"
"107","Sp Substance P Release Local Increase Of Sp","Volatile Organic Chemicals Activate TRPA1 Receptor to Induce Sensory Pulmonary Irritation","GO:0005184"
"108","Chronic Cough Respiratory Irritability","Volatile Organic Chemicals Activate TRPA1 Receptor to Induce Sensory Pulmonary Irritation","GO:0006954"
"109","Altered Gene Expression","Estrogen receptor activation leading to breast cancer","POSITIVE REGULATION OF GENE EXPRESSION"
"110","Altered Protein Production","Estrogen receptor activation leading to breast cancer","GO:0006412"
"111","Increased Motility","Estrogen receptor activation leading to breast cancer","GO:0048870"
"112","Increased Second Messenger Production","Estrogen receptor activation leading to breast cancer","GO:0019932"
"113","Narcosis","AOP from chemical insult to cell death","GO:0007009"
"114","Direct Mitochondrial Inhibition","AOP from chemical insult to cell death","CTOME ACTIVATION OF BAD AND TRANSLOCATION TO MITOCHONDRIA"
"115","Reduction Ecdysis Motoneuron Bursts","Ecdysone receptor agonism leading to incomplete ecdysis associated mortality","GO:0019226"
"116","Reduction Excitatory Postsynaptic Potential","Ecdysone receptor agonism leading to incomplete ecdysis associated mortality","DISRUPTION OF POSTSYNAPTIC SIGNALLING BY CNV"
"117","Reproductive Failure","NADPH oxidase and P38 MAPK activation leading to reproductive failure in Caenorhabditis elegans","GO:0000003"
"118","Increased Oxidative Stress","NADPH oxidase and P38 MAPK activation leading to reproductive failure in Caenorhabditis elegans","OXIDATIVE STRESS"
"119","Increased Oxidative Damage","NADPH oxidase and P38 MAPK activation leading to reproductive failure in Caenorhabditis elegans","OXIDATIVE DAMAGE"
"120","Increase Oxidative Stress / Activation Pmk-1 P38 Mapk","NADPH oxidase and P38 MAPK activation leading to reproductive failure in Caenorhabditis elegans","OXIDATIVE STRESS"
"121","Activation Hif-1","NADPH oxidase and P38 MAPK activation leading to reproductive failure in Caenorhabditis elegans","HIF1A AND PPARG REGULATION OF GLYCOLYSIS"
"122","Increased Dna Damage-Repair","NADPH oxidase and P38 MAPK activation leading to reproductive failure in Caenorhabditis elegans","DNA DAMAGE RESPONSE"
"123","Increased Dna Damage-Repair","NADPH oxidase and P38 MAPK activation leading to reproductive failure in Caenorhabditis elegans","GO:0006281"
"124","Activation Jak/Stat Pathway","Janus kinase (JAK)/Signal transducer and activator of transcription (STAT) and Transforming growth factor (TGF)-beta pathways activation leading to reproductive failure","G JAK STAT SIGNALING PATHWAY"
"125","Activation Tgf-Beta Pathway","Janus kinase (JAK)/Signal transducer and activator of transcription (STAT) and Transforming growth factor (TGF)-beta pathways activation leading to reproductive failure","G TGF BETA SIGNALING PATHWAY"
"126","Up Regulation Srebf2","Perturbation of cholesterol and glutathione homeostasis leading to hepatotoxicity: Integrated multi-OMICS approach for building AOP","CTOME ACTIVATION OF GENE EXPRESSION BY SREBF SREBP"
"127","Up Regulation Unsaturated Fatty Acid","Perturbation of cholesterol and glutathione homeostasis leading to hepatotoxicity: Integrated multi-OMICS approach for building AOP","GO:0006636"
"128","Down Regulation Gss And Gsts Gene","Perturbation of cholesterol and glutathione homeostasis leading to hepatotoxicity: Integrated multi-OMICS approach for building AOP","GO:0004364"
"129","Glutathione Synthesis","Perturbation of cholesterol and glutathione homeostasis leading to hepatotoxicity: Integrated multi-OMICS approach for building AOP","GLUTATHIONE METABOLIC PROCESS"
"130","Activation 3-Hydroxy-3-Methylglutaryl-Coa Reductase Gene","Perturbation of cholesterol and glutathione homeostasis leading to hepatotoxicity: Integrated multi-OMICS approach for building AOP","GO:0003857"
"131","Perturbation Of Cholesterol","Perturbation of cholesterol and glutathione homeostasis leading to hepatotoxicity: Integrated multi-OMICS approach for building AOP","ABNORMAL CIRCULATING CHOLESTEROL CONCENTRATION"
"132","Reduction Gonadotropins Circulating Concentrations","Androgen receptor agonism leading to reproductive dysfunction (in repeat-spawning fish)","ABNORMAL CIRCULATING RENIN"
"133","Glutathione Homeostasis","Perturbation of cholesterol and glutathione homeostasis leading to hepatotoxicity: Integrated multi-OMICS approach for building AOP","GLUTATHIONE METABOLIC PROCESS"
"134","Activation Jnk","Activation of c-Jun N-terminal kinase (JNK) and Forkhead box O (FOXO) and reduction of WNT pathways leading to reproductive failure: Integrated multi-OMICS approach for AOP building","JNK CASCADE"
"135","Activation Foxo","Activation of c-Jun N-terminal kinase (JNK) and Forkhead box O (FOXO) and reduction of WNT pathways leading to reproductive failure: Integrated multi-OMICS approach for AOP building","CTOME FOXO MEDIATED TRANSCRIPTION"
"136","Inhibition Wnt Pathway","Activation of c-Jun N-terminal kinase (JNK) and Forkhead box O (FOXO) and reduction of WNT pathways leading to reproductive failure: Integrated multi-OMICS approach for AOP building","REGULATION OF WNT SIGNALING PATHWAY"
"137","Defect Of Embryogenesis","Activation of c-Jun N-terminal kinase (JNK) and Forkhead box O (FOXO) and reduction of WNT pathways leading to reproductive failure: Integrated multi-OMICS approach for AOP building","GO:0009790"
"138","Depletion Gsh","Glutathione conjugation leading to reproductive dysfunction via oxidative stress","G GLUTATHIONE METABOLISM"
"139","Down Regulation Gulcose-6-Phosphate Dehydrogenase","Oxidation of iron in hemoglobin leading to hematotoxicity","ABNORMAL LACTATE DEHYDROGENASE LEVEL"
"140","N/A Hepatotoxicity Hepatopathy Including A Constellation Of Observable Effects","Sustained AhR Activation leading to Rodent Liver Tumours","ABNORMALITY OF THE LIVER"
"141","N/A Oxidative Stress","Cyp2E1 Activation Leading to Liver Cancer","OXIDATIVE STRESS"
"142","Decreased Hsd17b10 Expression","Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis","STEROID HORMONE MEDIATED SIGNALING PATHWAY"
"143","Induction Ikb Inhibitory Protein","Glucocorticoid Receptor Activation Leading to Increased Disease Susceptibility","CTOME IKBA VARIANT LEADS TO EDA ID"
"144","Inhibition Inducible Nitric Oxide Synthase By Metabolite Cga 265307","Inhibition of iNOS, hepatotoxicity, and regenerative proliferation leading to liver tumors","REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY"
"145","Increase Inflammation","Cholestatic Liver Injury induced by Inhibition of the Bile Salt Export Pump (ABCB11)","GO:0006954"
"146","Suppression Inflammatory Cytokines","Glucocorticoid Receptor Activation Leading to Increased Disease Susceptibility","GO:0002534"
"147","N/A Insufficient Or Incorrect Dna Repair","Alkylation of DNA in male pre-meiotic germ cells leading to heritable mutations","GO:0006281"
"148","Increase Liver And Splenic Hemosiderosis","Oxidation of iron in hemoglobin leading to hematotoxicity","ABNORMAL LIVER MORPHOLOGY"
"149","Decreased Androgen Receptor Activity","Inhibition of 17Î±-hydrolase/C 10,20-lyase (Cyp17A1) activity leads to birth reproductive defects (cryptorchidism) in male (mammals)","GO:0004882"
"150","Induction Liver âDysfunctionalâ Changes By Cga 330050","Inhibition of iNOS, hepatotoxicity, and regenerative proliferation leading to liver tumors","ABNORMAL LIVER MORPHOLOGY"
"151","Activation Long Term Ahr Receptor Driven Direct And Indirect Gene Expression Changes","Sustained AhR Activation leading to Rodent Liver Tumours","CTOME ARYL HYDROCARBON RECEPTOR SIGNALLING"
"152","Decreased Long-Term Potentiation Ltp","Calcium-mediated neuronal ROS production and energy imbalance","GO:0060291"
"153","Activation Lxr","LXR activation leading to hepatic steatosis","LIVER X RECEPTOR PATHWAY"
"154","Decreased Lymphocytes","Glucocorticoid Receptor Activation Leading to Increased Disease Susceptibility","LYMPHOCYTE APOPTOTIC PROCESS"
"155","N/A Methemoglobinemia Decreased Hemoglobin Hematocrit Red Blood Cell Number","Oxidation of iron in hemoglobin leading to hematotoxicity","PURE RED CELL APLASIA"
"156","Disruption Mitochondrial Electron Transport Chain","Calcium-mediated neuronal ROS production and energy imbalance","ELECTRON TRANSPORT CHAIN"
"157","Decreased Mitochondrial Fatty Acid Beta-Oxidation","Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis","GO:0006635"
"158","Activation Ahr","Aryl hydrocarbon receptor activation leading to early life stage mortality, via increased COX-2","ARYL HYDROCARBON RECEPTOR PATHWAY"
"159","Altered Neuroanatomy","XX Inhibition of Sodium Iodide Symporter and Subsequent Adverse Neurodevelopmental Outcomes in Mammals","GO:0048856"
"160","N/A Neuroinflammation","Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration with impairment in learning and memory in aging","NEUROINFLAMMATION"
"161","N/A Neuronal Dysfunction","Increased LCN2/iron complex leading to neurological disorders","GO:0036475"
"162","Altered Neurophysiology","XX Inhibition of Sodium Iodide Symporter and Subsequent Adverse Neurodevelopmental Outcomes in Mammals","NEURON CELLULAR HOMEOSTASIS"
"163","Decreased Nitric Oxide","Calcium-mediated neuronal ROS production and energy imbalance","RESPONSE TO NITRIC OXIDE"
"164","Inhibition Nmdars","Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration with impairment in learning and memory in aging","CTOME ACTIVATION OF AMPK DOWNSTREAM OF NMDARS"
"165","Inhibition Nuclear Factor Kappa B Nf-Kb","Glucocorticoid Receptor Activation Leading to Increased Disease Susceptibility","GO:0007249"
"166","Altered Regulation Alpha Hemoglobin","Oxidation of iron in hemoglobin leading to hematotoxicity","HEMOGLOBIN METABOLIC PROCESS"
"167","Bile Accumulation Pathological Condition","Cholestatic Liver Injury induced by Inhibition of the Bile Salt Export Pump (ABCB11)","CTOME BILE ACID AND BILE SALT METABOLISM"
"168","Decreased Pck1 Expression Control Point For Glycolysis/Gluconeogenesis Pathway","AhR activation leading to hepatic steatosis","GLYCOLYSIS AND GLUCONEOGENESIS"
"169","Reduction Plasma 17beta-Estradiol Concentrations","Aromatase (Cyp19a1) reduction leading to impaired fertility in adult female","RESPONSE TO ESTRADIOL"
"170","Increase Plasma Vitellogenin Concentrations","Estrogen receptor agonism leading to reproductive dysfunction","DECREASED PLASMA CARNITINE"
"171","Reduction Plasma Vitellogenin Concentrations","Aromatase inhibition leading to reproductive dysfunction","DECREASED PLASMA CARNITINE"
"172","Activation Androgen Receptor","Androgen receptor agonism leading to long anogenital distance in female offspring","GO:0004882"
"173","Reduction Testosterone Level","Decreased testosterone synthesis leading to short anogenital distance (AGD) in male (mammalian) offspring","TESTOSTERONE BIOSYNTHETIC PROCESS"
"174","Decreased Ppar-Alpha Activation","Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis","GO:0035357"
"175","Decreased Ppar-Beta Activation","Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis","GO:0035357"
"176","Decreased Ppar-Gamma Activation","Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis","GO:0035357"
"177","Reduction Prostaglandin E2 Concentration","Cyclooxygenase inhibition leading reproductive failure","PROSTAGLANDIN SYNTHESIS AND REGULATION"
"178","Alkylation Protein","Protein Alkylation leading to Liver Fibrosis","GO:0008213"
"179","Activation Pxr/Sxr","Percellome Toxicogenomics Approach for AOP Building: Case study on Pentachlorophenol","GO:0004872"
"180","Increase Rbc Congestion In Liver","Oxidation of iron in hemoglobin leading to hematotoxicity","ABNORMAL LIVER MORPHOLOGY"
"181","Agonism Androgen Receptor","Androgen receptor agonism leading to reproductive dysfunction (in repeat-spawning fish)","GO:0004882"
"182","Damaging Red Blood Cells; Hemolysis","Oxidation of iron in hemoglobin leading to hematotoxicity","ABNORMALITY OF BLOOD AND BLOOD FORMING TISSUES"
"183","Increase Renal Pathology Due To Vtg Deposition","Estrogen receptor agonism leading to reproductive dysfunction","ABNORMALITY OF ADRENAL PHYSIOLOGY"
"184","N/A Reproductive Failure","Cyclooxygenase inhibition leading reproductive failure","GO:0044703"
"185","N/A Androgen Receptor Antagonism","Androgen receptor (AR) antagonism leading to short anogenital distance (AGD) in male (mammalian) offspring","GO:0004882"
"186","Activation Srebp-1c","LXR activation leading to hepatic steatosis","STEROL REGULATORY ELEMENTBINDING PROTEINS SREBP SIGNALLIN"
"187","Decrease Steroidogenic Acute Regulatory Protein Star","PPARÎ± activation in utero leading to impaired fertility in males","STEROID HORMONE MEDIATED SIGNALING PATHWAY"
"188","Induction Sustained Cell Proliferation","Inhibition of iNOS, hepatotoxicity, and regenerative proliferation leading to liver tumors","NEGATIVE REGULATION OF FAT CELL PROLIFERATION"
"189","Induction Sustained Hepatotoxicity","Inhibition of iNOS, hepatotoxicity, and regenerative proliferation leading to liver tumors","ABNORMALITY OF THE LIVER"
"190","Activation/Proliferation T-Cells","Covalent Protein binding leading to Skin Sensitisation","GO:0008283"
"191","Reduction Testosterone Synthesis By Ovarian Theca Cells","Androgen receptor agonism leading to reproductive dysfunction (in repeat-spawning fish)","GO:0061370"
"192","Reduction Angiogenesis","Disruption of VEGFR Signaling Leading to Developmental Defects","GO:0001525"
"193","Decreased Thyroxine T4 In Serum","Inhibition of Thyroperoxidase and Subsequent Adverse Neurodevelopmental Outcomes in Mammals","HUMAN THYROID STIMULATING HORMONE TSH SIGNALING PATHWAY"
"194","Decreased Thyroxine T4 In Serum","Inhibition of Thyroperoxidase and Subsequent Adverse Neurodevelopmental Outcomes in Mammals","ABNORMAL THYROID HORMONE LEVEL"
"195","Reduction Vitellogenin Synthesis In Liver","Aromatase inhibition leading to reproductive dysfunction","ABNORMAL LIVER MORPHOLOGY"
"196","Decreased Transcription Of Genes By Ar","Androgen receptor antagonism leading to adverse effects in the male foetus (mammals)","GO:0010468"
"197","Accumulation Triglyceride","LXR activation leading to hepatic steatosis","TRIGLYCERIDE METABOLIC PROCESS"
"198","Induction Upregulation Of Glucuronyltransferase Activity","Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals","GO:0003824"
"199","Insufficiency Vascular","Disruption of VEGFR Signaling Leading to Developmental Defects","GO:0008015"
"200","Reduction 17beta-Estradiol Synthesis By Ovarian Granulosa Cells","Aromatase (Cyp19a1) reduction leading to impaired fertility in adult female","GO:0006703"
"201","Inhibition Vegfr2","Disruption of VEGFR Signaling Leading to Developmental Defects","CTOME VEGFR2 MEDIATED CELL PROLIFERATION"
"202","Increase Vitellogenin Synthesis In Liver","Estrogen receptor agonism leading to reproductive dysfunction","ABNORMAL LIVER MORPHOLOGY"
"203","Reduction Vitellogenin Accumulation Into Oocytes And Oocyte Growth/Development","Aromatase inhibition leading to reproductive dysfunction","GO:0006898"
"204","Alteration Wnt Pathway","Androgen receptor antagonism leading to adverse effects in the male foetus (mammals)","GO:0016055"
"205","Increase Allergic Respiratory Hypersensitivity Response","Covalent Binding, Protein, leading to Increase, Allergic Respiratory Hypersensitivity Response","IMMUNOLOGIC HYPERSENSITIVITY"
"206","Altered Cardiovascular Development/Function","Aryl hydrocarbon receptor activation leading to early life stage mortality, via reduced VEGF","GO:0072358"
"207","N/A Cyanosis Occurs","Oxidation of iron in hemoglobin leading to hematotoxicity","CYANOSIS"
"208","Increased Disease Susceptibility","Glucocorticoid Receptor Activation Leading to Increased Disease Susceptibility","INCREASED SUSCEPTIBILITY TO FRACTURES"
"209","Accumulation Fatty Acid","Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis","ABNORMAL CIRCULATING FATTY ACID CONCENTRATION"
"210","Promotion Hepatocelluar Carcinoma","Uncharacterized liver damage leading to hepatocellular carcinoma","CARCINOMA"
"211","Increase Heritable Mutations In Offspring","Alkylation of DNA in male pre-meiotic germ cells leading to heritable mutations","NCRNAS INVOLVED IN WNT SIGNALING IN HEPATOCELLULAR CARCINOMA"
"212","N/A Impairment Of Reproductive Capacity","Androgen receptor antagonism leading to adverse effects in the male foetus (mammals)","ABNORMALITY OF REPRODUCTIVE SYSTEM PHYSIOLOGY"
"213","Altered Larval Development","Estrogen receptor agonism leading to reproductive dysfunction","HEART DEVELOPMENT"
"214","Impairment Learning And Memory","Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities","GO:0007612"
"215","N/A Liver Fibrosis","Protein Alkylation leading to Liver Fibrosis","ABNORMAL LIVER MORPHOLOGY"
"216","Formation Liver Tumor","Inhibition of iNOS, hepatotoxicity, and regenerative proliferation leading to liver tumors","ABNORMAL LIVER MORPHOLOGY"
"217","Malformation Male Reproductive Tract","PPARÎ± activation in utero leading to impaired fertility in males","MALE REPRODUCTIVE SYSTEM NEOPLASM"
"218","Increase Mortality","Ecdysone receptor agonism leading to incomplete ecdysis associated mortality","MORTALITY AGING"
"219","Increased Mortality","Acetylcholinesterase inhibition leading to acute mortality","MORTALITY AGING"
"220","N/A Neurodegeneration","Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration with impairment in learning and memory in aging","NEURODEGENERATION"
"221","Cholestasis Pathology","Cholestatic Liver Injury induced by Inhibition of the Bile Salt Export Pump (ABCB11)","CHOLESTASIS"
"222","Inhibition Aromatase","Aromatase inhibition leading to reproductive dysfunction","GO:0070330"
"223","Altered Reproductive Behaviour","Estrogen receptor agonism leading to reproductive dysfunction","GO:0019098"
"224","Impaired Development Of Reproductive Organs","Estrogen receptor agonism leading to reproductive dysfunction","ABNORMALITY OF THE ABDOMINAL ORGANS"
"225","Formation Pro-Mutagenic Dna Adducts","AFB1: Mutagenic Mode-of-Action leading to Hepatocellular Carcinoma (HCC)","GO:0006305"
"226","Increased Induced Mutations In Critical Genes","AFB1: Mutagenic Mode-of-Action leading to Hepatocellular Carcinoma (HCC)","SOMATIC MUTATION"
"227","Tumorigenesis Hepatocellular Carcinoma","AFB1: Mutagenic Mode-of-Action leading to Hepatocellular Carcinoma (HCC)","HEPATOCELLULAR CARCINOMA"
"228","Aberrant Dendritic Morphology","Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities","GO:0048813"
"229","Reduced Presynaptic Release Of Glutamate","Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities","SYNAPTIC TRANSMISSION GLUTAMATERGIC"
"230","Overactivation Nmdars","Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.","CTOME ACTIVATION OF AMPK DOWNSTREAM OF NMDARS"
"231","Increased Intracellular Calcium Overload","Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.","POSITIVE REGULATION OF CALCIUM ION TRANSPORT"
"232","Covalent Binding Protein","Covalent Protein binding leading to Skin Sensitisation","GO:0005515"
"233","Activation Dendritic Cells","Covalent Protein binding leading to Skin Sensitisation","GO:0001775"
"234","Suppression Immune System","Glucocorticoid Receptor Activation Leading to Increased Disease Susceptibility","GO:0044414"
"235","Irregularities Ovarian Cycle","Aromatase (Cyp19a1) reduction leading to impaired fertility in adult female","GO:0042698"
"236","Impaired Fertility","Aromatase (Cyp19a1) reduction leading to impaired fertility in adult female","DECREASED FERTILITY"
"237","Reduction In Ovarian Granulosa Cells Aromatase Cyp19a1","Aromatase (Cyp19a1) reduction leading to impaired fertility in adult female","GO:0070330"
"238","Metabolism Of Afb1 Production Of Reactive Electrophiles","AFB1: Mutagenic Mode-of-Action leading to Hepatocellular Carcinoma (HCC)","GO:0008152"
"239","Inhibition Bile Salt Export Pump Abcb11","Cholestatic Liver Injury induced by Inhibition of the Bile Salt Export Pump (ABCB11)","BILE ACID AND BILE SALT TRANSPORT"
"240","Reduction Testosterone Synthesis In Leydig Cells","PPARÎ± activation leading to impaired fertility in adult male rodents","GO:0061370"
"241","Increase Luteinizing Hormone Lh","PPARÎ± activation leading to impaired fertility in adult male rodents","GO:0042446"
"242","Hyperplasia Leydig Cell","PPARÎ± activation leading to impaired fertility in adult male rodents","LEYDIG CELL DIFFERENTIATION"
"243","Increase Proliferation Leydig Cell","PPARÎ± activation leading to impaired fertility in adult male rodents","GO:0008283"
"244","Inhibition Na+/I- Symporter Nis","XX Inhibition of Sodium Iodide Symporter and Subsequent Adverse Neurodevelopmental Outcomes in Mammals","CELLULAR SODIUM ION HOMEOSTASIS"
"245","Increased Atrioventricular Block And Bradycardia","Sodium channel inhibition leading to congenital malformations","BRADYCARDIA"
"246","Increased Respiratory Distress/Arrest","Acetylcholinesterase inhibition leading to acute mortality","ABNORMAL RESPIRATORY SYSTEM MORPHOLOGY"
"247","Reduction Cholesterol Transport In Mitochondria","PPARÎ± activation leading to impaired fertility in adult male rodents","GO:0006839"
"248","Suppression Vldl Secretion","AhR activation leading to hepatic steatosis","GO:0046903"
"249","Inhibition Mitochondrial Fatty Acid Beta-Oxidation","AhR activation leading to hepatic steatosis","GO:0006635"
"250","Increased Triglyceride Formation","NR1I3 (CAR) suppression leading to hepatic steatosis","GO:0009058"
"251","Suppression Constitutive Androstane Receptor Nr1l3","NR1I3 (CAR) suppression leading to hepatic steatosis","CONSTITUTIVE ANDROSTANE RECEPTOR PATHWAY"
"252","Activation Srebf1","NR1I3 (CAR) suppression leading to hepatic steatosis","CTOME ACTIVATION OF GENE EXPRESSION BY SREBF SREBP"""
"253","Increased De Novo Fa Synthesis","NR1I3 (CAR) suppression leading to hepatic steatosis","GO:0006633"
"254","Increased Liver Steatosis","NR1I3 (CAR) suppression leading to hepatic steatosis","ABNORMALITY OF THE LIVER"
"255","Up Regulation Fas","NR1I3 (CAR) suppression leading to hepatic steatosis","FAS LIGAND FASL PATHWAY AND STRESS INDUCTION OF HEAT SHOCK PROTEINS HSP REGULATION"
"256","Increased Fa Influx","AhR activation leading to hepatic steatosis","GO:0015908"
"257","Up Regulation Ldlr Low Density Lipoprotein Receptor","AhR activation leading to hepatic steatosis","LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS"
"258","Increased Ldl Uptake","AhR activation leading to hepatic steatosis","GO:0006898"
"259","Inhibition Ppar Alpha","NR1I3 (CAR) suppression leading to hepatic steatosis","GO:0035357"
"260","Up Regulation Acetyl-Coa Carboxylase-1 Acc-1","NR1I3 (CAR) suppression leading to hepatic steatosis","CTOME FATTY ACYL COA BIOSYNTHESIS"
"261","Decreased Ketogenesis","NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis","CTOME SYNTHESIS OF KETONE BODIES"
"262","Activation Nrf2","NFE2L2/FXR activation leading to hepatic steatosis","NRF2 PATHWAY"
"263","Activation Nr1h4","NFE2L2/FXR activation leading to hepatic steatosis","FARNESOID X RECEPTOR PATHWAY"
"264","Decreased Dhb4/Hsd17b4","NFE2L2/FXR activation leading to hepatic steatosis","GO:0003824"
"265","Activation Lxr Alpha","NFE2L2/FXR activation leading to hepatic steatosis","LIVER X RECEPTOR PATHWAY"
"266","Activation Lxr Alpha","NFE2L2/FXR activation leading to hepatic steatosis","GO:0035357"
"267","Decrease Ovulation","Cyclooxygenase inhibition leading to reproductive dysfunction","GO:0030728"
"268","Decrease Ovulation","Cyclooxygenase inhibition leading to reproductive dysfunction","OVULATION"
"269","Reduction Ca And Hco3 Transport To Shell Gland","Cyclooxygenase inhibition leading reproductive failure","GO:0006816"
"270","Clonal Expansion/Cell Proliferation To Form Altered Hepatic Foci Ahf","AFB1: Mutagenic Mode-of-Action leading to Hepatocellular Carcinoma (HCC)","ABNORMAL FORM OF THE VERTEBRAL BODIES"
"271","Increased Insufficient Repair Or Mis-Repair Of Pro-Mutagenic Dna Adducts","AFB1: Mutagenic Mode-of-Action leading to Hepatocellular Carcinoma (HCC)","GO:0006281"
"272","Repressed Expression Of Steroidogenic Enzymes","Glucocorticoid Receptor (GR) Mediated Adult Leydig Cell Dysfunction Leading to Decreased Male Fertility","GO:0042446"
"273","Increased Apoptosis Decreased Leydig Cells","Glucocorticoid Receptor (GR) Mediated Adult Leydig Cell Dysfunction Leading to Decreased Male Fertility","ABNORMALITY OF THE LEYDIG CELLS"
"274","Increased Apoptosis Decreased Leydig Cells","Glucocorticoid Receptor (GR) Mediated Adult Leydig Cell Dysfunction Leading to Decreased Male Fertility","GO:0006915"
"275","Increase Ca++ Intracellular","Calcium-mediated neuronal ROS production and energy imbalance","POSITIVE REGULATION OF CALCIUM ION TRANSPORT"
"276","Inhibition Ca++ Atpase","Calcium-mediated neuronal ROS production and energy imbalance","REGULATION OF ATPASE ACTIVITY"
"277","Decreased Calcium Influx","Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities","GO:0006816"
"278","Decreased Sperm Quantity Or Quality In The Adult Decreased Fertility","Modulation of Adult Leydig Cell Function Subsequent to Proteomic Alterations in the Adult Leydig Cell","DECREASED FERTILITY"
"279","N/A Cell Injury/Death","Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.","REGULATION OF CELL DEATH"
"280","Activation Nicotinic Acetylcholine Receptor","Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony death/failure 1","GO:0015464"
"281","Abnormal Foraging Activity And Behavior","Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony death/failure 1","ABNORMAL SOCIAL BEHAVIOR"
"282","Reduced Brood Care","Nicotinic acetylcholine receptor activation contributes to abnormal role change within the worker bee caste leading to colony death failure 1","GO:0019098"
"283","Proliferation Cell Proliferation In The Absence Of Cytotoxicity","Uncharacterized liver damage leading to hepatocellular carcinoma","GO:0008283"
"284","Accumulation Damaged Mitochondrial Dna","Nicotinic acetylcholine receptor activation contributes to accumulation of damaged mitochondrial DNA and leads to colony loss/failure","GO:0009611"
"285","Accelerated Aging","Nicotinic acetylcholine receptor activation contributes to accumulation of damaged mitochondrial DNA and leads to colony loss/failure","GO:0007568"
"286","Increase Energetic Demands And Therefore Metabolic Stress","Increased metabolic stress contributes to abnormal foraging and leads to colony loss/failure","OXIDATIVE STRESS"
"287","Increased Appetite And Hunger","Increased metabolic stress contributes to abnormal foraging and leads to colony loss/failure","REGULATION OF APPETITE"
"288","Impaired Development","Suppression of immune system contributes to impaired development and leads to colony loss/failure","HEART DEVELOPMENT"
"289","Decreased Glucose Oxidase Enzyme Activity","Decrease Glucose oxidase activity contributes to reduction of antiseptic in food and leads to colony loss/failure","GO:0046562"
"290","Decreased Hydrogen Peroxide Production","Decrease Glucose oxidase activity contributes to reduction of antiseptic in food and leads to colony loss/failure","GO:0050665"
"291","Inhibition Sodium Channel","Sodium channel inhibition leading to reduced survival","REGULATION OF SODIUM ION TRANSPORT"
"292","Reduced Swimming Speed","Sodium channel inhibition leading to reduced survival","LOCOMOTORY BEHAVIOR"
"293","N/A Hypoxia","Sodium channel inhibition leading to congenital malformations","CTOME CELLULAR RESPONSE TO HYPOXIA"
"294","Increased Amputations","Sodium channel inhibition leading to congenital malformations","INCREASED HEMOGLOBIN"
"295","Inhibition Ether-A-Go-Go Erg Voltage-Gated Potassium Channel","Ether-a-go-go (ERG) voltage-gated potassium channel inhibition leading to reduced survival","REGULATION OF POTASSIUM ION TRANSPORT"
"296","Modulation Sodium Channel","Axonal sodium channel modulation leading to acute mortality","REGULATION OF SODIUM ION TRANSPORT"
"297","Prolonged Depolarization Of Neuronal Membrane","Axonal sodium channel modulation leading to acute mortality","GO:0051899"
"298","Overactivation Neuronotransmitter Release","Axonal sodium channel modulation leading to acute mortality","GO:0007269"
"299","Overactivation Muscle Contraction","Axonal sodium channel modulation leading to acute mortality","GO:0006936"
"300","Increased Ataxia Paralysis Or Hyperactivity","Axonal sodium channel modulation leading to acute mortality","HYPERACTIVITY"
"301","Occurrence Epileptic Seizure","Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures in adult brain","PSYCHOGENIC NON EPILEPTIC SEIZURE"
"302","Occurrence A Paroxysmal Depolarizing Shift","Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures in adult brain","GO:0051899"
"303","Decreased Neuronal Network Function In Adult Brain","Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.","GO:0099536"
"304","Increased Locomotion","5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to population decline","GO:0040011"
"305","Increased Serotonin 5-Ht","5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to decreased shelter seeking and increased predation","GO:0001820"
"306","Decreased Anxiety","5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to decreased shelter seeking and increased predation","SEROTONIN AND ANXIETY"
"307","Decrease Histaminergic Neuron Excitation","Histamine (H2) receptor antagonism leading to reduced survival","UPPER MOTOR NEURON DYSFUNCTION"
"308","Decreased Locomotion","Histamine (H2) receptor antagonism leading to reduced survival","GO:0040011"
"309","Antagonism Histamine Receptor H2","Histamine (H2) receptor antagonism leading to reduced survival","RESPONSE TO HISTAMINE"
"310","Reduction Ionotropic Gaba Receptor Chloride Channel Conductance","Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures in adult brain","GO:0022851"
"311","Decrease Bioactivation Of Testosterone","Modulation of Adult Leydig Cell Function Subsequent Glucocorticoid Activation in the Fetal Testis","GO:0061370"
"312","Desensitization Nicotinic Acetylcholine Receptor","Nicotinic acetylcholine receptor activation followed by desensitization contributes to abnormal foraging and directly leads to colony loss/failure","GO:0030545"
"313","Overwhelmed Mitochondrial Dna Repair Mechanisms","Nicotinic acetylcholine receptor activation contributes to accumulation of damaged mitochondrial DNA and leads to colony loss/failure","GO:0006281"
"314","Binding At Picrotoxin Site Igabar Chloride Channel","Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures in adult brain","REGULATION OF CHLORIDE TRANSPORT"
"315","Reduction Neuronal Synaptic Inhibition","Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures in adult brain","GO:0007268"
"316","Reduced Prostaglandin F2alpha Concentration Plasma","Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of female spawning behavior","PROSTAGLANDIN SYNTHESIS AND REGULATION"
"317","Reduced Prostaglandin F2alpha Synthesis Ovary","Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of female spawning behavior","GO:0001516"
"318","Reduced Spawning Behavior","Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of female spawning behavior","REPRODUCTIVE BEHAVIOR"
"319","Reduced Ability To Attract Spawning Mates","Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of female spawning behavior","MATING BEHAVIOR"
"320","Reduced Reproductive Success","Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of female spawning behavior","GO:0000003"
"321","Reduced Pheromone Release","Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of pheromone release","GPCRS CLASS C METABOTROPIC GLUTAMATE PHEROMONE"
"322","Accumulation Collagen","Protein Alkylation leading to Liver Fibrosis","GO:0032964"
"323","Decreased Prostaglandin F2alpha Synthesis Ovary","Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of pheromone release","GO:0001516"
"324","Generation Amplified Excitatory Postsynaptic Potential Epsp","Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures in adult brain","DISRUPTION OF POSTSYNAPTIC SIGNALLING BY CNV"
"325","Reduced Prostaglandins Ovary","Cyclooxygenase inhibition leading to reproductive dysfunction","ABNORMALITY OF THE OVARY"
"326","Reduced Prostaglandin E2 Concentration Hypothalamus","Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition","ABNORMAL HYPOTHALAMUS PHYSIOLOGY"
"327","Reduced Gonadotropin Releasing Hormone Hypothalamus","Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition","HYPOTHALAMIC GONADOTROPIN RELEASING HORMONE DEFICIENCY"
"328","Reduced Luteinizing Hormone Lh Plasma","Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition","DECREASED CIRCULATING LUTEINIZING HORMONE LEVEL"
"329","Reduced Maturation Inducing Steroid Plasma","Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition","STEROID HORMONE MEDIATED SIGNALING PATHWAY"
"330","Reduced Maturation Inducing Steroid Receptor Signalling Oocyte","Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition","GO:0003707"
"331","Increased Cyclic Adenosine Monophosphate","Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition","ELEVATED RED CELL ADENOSINE DEAMINASE LEVEL"
"332","Reduced Meiotic Prophase I/Metaphase I Transition Oocyte","Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition","G OOCYTE MEIOSIS"
"333","Upregulated Spindle Assembly Checkpoint Protein Mad2-Oocyte","Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint","REGULATION OF SPINDLE CHECKPOINT"
"334","Increased Chromosome Misseggregation","Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint","GO:0007059"
"335","Impaired Ion Channels","Altered ion channel activity leading impaired heart function","GO:0005216"
"336","Altered Action Potential","Altered ion channel activity leading impaired heart function","GO:0001508"
"337","Increased Cardiac Arrthymia","Altered ion channel activity leading impaired heart function","ABNORMAL CARDIAC TEST"
"338","Increased Accumulation Of Alpha2u Microglobulin Proximal Tubular Epithelium","Alpha2u-microglobulin cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat)","ABNORMAL CORNEAL EPITHELIUM MORPHOLOGY"
"339","Increase Cytotoxicity Renal Tubular Cell","Alpha2u-microglobulin cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat)","RENAL TUBULAR DYSFUNCTION"
"340","Increase Regenerative Cell Proliferation Tubular Epithelial Cells","Alpha2u-microglobulin cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat)","GO:0050673"
"341","Increase Adenomas/Carcinomas Renal Tubular","Alpha2u-microglobulin cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat)","RENAL TUBULAR DYSFUNCTION"
"342","Increased Binding Of Chemicals To 2u Serum","Alpha2u-microglobulin cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat)","GO:0005488"
"343","Activation Constitutive Androstane Receptor","Constitutive androstane receptor activation leading to hepatocellular adenomas and carcinomas in the mouse and the rat","CONSTITUTIVE ANDROSTANE RECEPTOR PATHWAY"
"344","Increase Mitogenic Cell Proliferation Hepatocytes","Constitutive androstane receptor activation leading to hepatocellular adenomas and carcinomas in the mouse and the rat","GO:0008283"
"345","Binding Tubulin","Chemical binding to tubulin in oocytes leading to aneuploid offspring","GO:0015631"
"346","Increase Adenomas/Carcinomas Hepatocellular","Constitutive androstane receptor activation leading to hepatocellular adenomas and carcinomas in the mouse and the rat","HEPATOCELLULAR CARCINOMA"
"347","Depolymerization Microtubule","Chemical binding to tubulin in oocytes leading to aneuploid offspring","MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION"
"348","Disorganization Spindle","Chemical binding to tubulin in oocytes leading to aneuploid offspring","GO:0007051"
"349","Altered Chromosome Number","Chemical binding to tubulin in oocytes leading to aneuploid offspring","CHROMOSOME BREAKAGE"
"350","Inhibition Pyruvate Dehydrogenase Kinase Pdk Enzyme","Inhibition of pyruvate dehydrogenase kinase leading to hepatocellular adenomas and carcinomas (in mouse and rat)","GO:0004738"
"351","Increased Induction Of Pyruvate Dehydrogenase Pdh","Inhibition of pyruvate dehydrogenase kinase leading to hepatocellular adenomas and carcinomas (in mouse and rat)","GO:0004738"
"352","Increase Necrosis Terminal Bronchiolar Cells","Cytotoxicity leading to bronchioloalveolar adenomas and carcinomas (in mouse)","CTOME REGULATED NECROSIS"
"353","Increase Regenerative Cell Proliferation Terminal Bronchiolar Epithelial Cells","Cytotoxicity leading to bronchioloalveolar adenomas and carcinomas (in mouse)","GO:0050673"
"354","Increase Hyperplasia Terminal Bronchiolar Cells","Cytotoxicity leading to bronchioloalveolar adenomas and carcinomas (in mouse)","ADRENAL HYPERPLASIA"
"355","Increase Adenomas/Carcinomas Bronchioloalveolar","Cytotoxicity leading to bronchioloalveolar adenomas and carcinomas (in mouse)","ABNORMAL LUNG MORPHOLOGY"
"356","Increase Hypertrophy And Proliferation Follicular Cell","Inhibition of iodide pump activity leading to follicular cell adenomas and carcinomas (in rat and mouse)","GO:0008283"
"357","Increase Hyperplasia Follicular Cells","Inhibition of iodide pump activity leading to follicular cell adenomas and carcinomas (in rat and mouse)","ADRENAL HYPERPLASIA"
"358","Increase Adenomas/Carcinomas Follicular Cell","Inhibition of iodide pump activity leading to follicular cell adenomas and carcinomas (in rat and mouse)","FOLLICULAR HYPERKERATOSIS"
"359","Decreased Testosterone Binding To Androgen Receptor Hypothalamus","Decrease in androgen receptor activity leading to Leydig cell tumors (in rat)","GO:0005102"
"360","Increase Hyperplasia Leydig Cells","Decrease in androgen receptor activity leading to Leydig cell tumors (in rat)","ABNORMALITY OF THE LEYDIG CELLS"
"361","Increase Leydig Cell Tumors","Decrease in androgen receptor activity leading to Leydig cell tumors (in rat)","LEYDIG CELL DIFFERENTIATION"
"362","Increase Dopaminergic Activity","Increased dopaminergic activity leading to endometrial adenocarcinomas (in Wistar rat)","GO:0001963"
"363","Decreased Prolactin","Increased dopaminergic activity leading to endometrial adenocarcinomas (in Wistar rat)","ABNORMAL PROLACTIN LEVEL"
"364","Increased Estrogen Receptor Er Activity","Alcohol dehydrogenase leading to reproductive dysfunction","GO:0030284"
"365","Decreased Progesterone From Corpus Luteum","Increased dopaminergic activity leading to endometrial adenocarcinomas (in Wistar rat)","GO:0042701"
"366","Altered Meiotic Chromosome Dynamics","Chemical binding to tubulin in oocytes leading to aneuploid offspring","CHROMOSOME BREAKAGE"
"367","Increased Luteinizing Hormone Lh","Decrease in androgen receptor activity leading to Leydig cell tumors (in rat)","DECREASED CIRCULATING LUTEINIZING HORMONE LEVEL"
"368","Increased Kidney Failure","Kidney toxicity induced by activation of 5HT2C","ABNORMALITY OF ADRENAL PHYSIOLOGY"
"369","Activation Glutamate-Gated Chloride Channel","Glutamate-gated chloride channel activation leading to acute mortality","GO:0005254"
"370","Increased Chloride Conductance","Glutamate-gated chloride channel activation leading to acute mortality","GO:1902476"
"371","Activation Ionotropic Gaba Receptor Chloride Channel","Ionotropic gamma-aminobutyric acid receptor activation mediated neurotransmission inhibition leading to mortality","GO:0022851"
"372","Hyperpolarisation Neuron","Glutamate-gated chloride channel activation leading to acute mortality","ABNORMAL NEURON MORPHOLOGY"
"373","N/A Ataxia Paralysis Or Hyperactivity","Glutamate-gated chloride channel activation leading to acute mortality","HYPERACTIVITY"
"374","Induction Ataxia Paralysis Or Hyperactivity","Glutamate-gated chloride channel activation leading to acute mortality","HYPERACTIVITY"
"375","Inhibition 4-Hydroxyphenyl-Pyruvate Dioxygenase Hppd Enzyme","HPPD inhibition leading to corneal papillomas and carcinomas (in rat)","PYRUVATE METABOLIC PROCESS"
"376","Increase Hyperplasia Renal Tubular Cells","Alpha2u-microglobulin cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat)","RENAL TUBULAR DYSFUNCTION"
"377","Increase Cytotoxicity","Inhibition of pyruvate dehydrogenase kinase leading to hepatocellular adenomas and carcinomas (in mouse and rat)","GO:0001909"
"378","Increase Oxidative Metabolism","Inhibition of pyruvate dehydrogenase kinase leading to hepatocellular adenomas and carcinomas (in mouse and rat)","GO:0045333"
"379","Production Critical Metabolites Cga 330050 And Cga 265307","Inhibition of iNOS, hepatotoxicity, and regenerative proliferation leading to liver tumors","GO:0008152"
"380","Decrease Serum Thyroid Hormone T4/T3","Thyroid peroxidase (TPO) inhibition leads to periventricular heterotopia formation in the developing rat brain","ABNORMAL THYROID HORMONE LEVEL"
"381","Increase Hyperplasia Glandular Epithelial Cells Of Endometrium","Increased dopaminergic activity leading to endometrial adenocarcinomas (in Wistar rat)","ABNORMALITY OF THE ENDOMETRIUM"
"382","Increase Endometrial Adenocarcinomas","Increased dopaminergic activity leading to endometrial adenocarcinomas (in Wistar rat)","ENDOMETRIAL CANCER"
"383","Increase Preneoplastic Foci Hepatocytes","Constitutive androstane receptor activation leading to hepatocellular adenomas and carcinomas in the mouse and the rat","LIPID ACCUMULATION IN HEPATOCYTES"
"384","Increased Plasma Tyrosine","HPPD inhibition leading to corneal papillomas and carcinomas (in rat)","DECREASED PLASMA CARNITINE"
"385","Increase Inflammation Corneal Cells","HPPD inhibition leading to corneal papillomas and carcinomas (in rat)","GO:0006954"
"386","Increase Regenerative Cell Proliferation Corneal Cells","HPPD inhibition leading to corneal papillomas and carcinomas (in rat)","GO:0008283"
"387","Increase Papillomas/Carcinomas Squamous Cells","HPPD inhibition leading to corneal papillomas and carcinomas (in rat)","SQUAMOUS CELL CARCINOMA"
"388","Reduction Cumulative Fecundity And Spawning","Estrogen receptor agonism leading to reproductive dysfunction","DECREASED FERTILITY"
"389","Increase Regenerative Cell Proliferation Forestomach Epithelial Cells","Epithelial cytotoxicity leading to forestomach tumors (in mouse and rat)","GO:0008283"
"390","Increase Regenerative Cell Proliferation Hepatocytes","Chronic cytotoxicity leading to hepatocellular adenomas and carcinomas (in mouse and rat)","GO:0008283"
"391","Inhibition Cyclooxygenase Activity","Cyclooxygenase inhibition leading reproductive failure","GO:0004666"
"392","Increased Leutinizing Hormone Lh","Inhibition of 5Î±-reductase leading to Leydig cell tumors (in rat)","LUTEINIZING"
"393","Increase Urinary Bladder Calculi","Urinary bladder calculi leading to urothelial papillomas and carcinomas (in mouse and rat)","ABNORMALITY OF THE BLADDER"
"394","Increase Regenerative Cell Proliferation Urothelial Cells","Urinary bladder calculi leading to urothelial papillomas and carcinomas (in mouse and rat)","GO:0008283"
"395","Increase Hyperplasia Urothelial","Urinary bladder calculi leading to urothelial papillomas and carcinomas (in mouse and rat)","ADRENAL HYPERPLASIA"
"396","Inhibition Prolyl Hydroxylases","Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation","GO:0003824"
"397","Increased Hif-1 Heterodimer","Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation","HIF1A AND PPARG REGULATION OF GLYCOLYSIS"
"398","Decreased 3-Hydroxyacyl-Coa Dehydrogenase Type-2 Activity","Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis","GO:0003857"
"399","Up Regulation Cyp1a1","AhR activation leading to hepatic steatosis","ARYL HYDROCARBON RECEPTOR PATHWAY"
"400","Decreased Aromatase Cyp19a1 Mrna","Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation","GO:0070330"
"401","Increased Hif-1 Alpha Transcription","Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription","HIF1A AND PPARG REGULATION OF GLYCOLYSIS"
"402","Inhibition Hmg-Coa Reductase","HMG-CoA reductase inhibition leading to decreased fertility","NADPH REGENERATION"
"403","Decreased Mevalonate","HMG-CoA reductase inhibition leading to decreased fertility","MEVALONATE PATHWAY"
"404","Decreased Cholesterol","HMG-CoA reductase inhibition leading to decreased fertility","ABNORMAL CIRCULATING CHOLESTEROL CONCENTRATION"
"405","Malformed Male Reproductive Tract","HMG-CoA reductase inhibition leading to decreased fertility","MALE REPRODUCTIVE SYSTEM NEOPLASM"
"406","Increased Serum Creatinine","Kidney dysfunction by decreased thyroid hormone","INCREASED SERUM SEROTONIN"
"407","Occurrence Kidney Toxicity","Kidney dysfunction by decreased thyroid hormone","ABNORMALITY OF ADRENAL PHYSIOLOGY"
"408","Occurrence Cytoplasmic Vacuolization Renal Tubule","Kidney dysfunction by decreased thyroid hormone","ABNORMAL RENAL TUBULE MORPHOLOGY"
"409","Decreased Glomerular Filtration","Kidney dysfunction by decreased thyroid hormone","GLOMERULAR SCLEROSIS"
"410","Decreased Renal Plasma Flow","Kidney dysfunction by decreased thyroid hormone","DECREASED PLASMA CARNITINE"
"411","Decreased Sodium Reabsorption","Kidney dysfunction by decreased thyroid hormone","ABNORMAL BLOOD SODIUM CONCENTRATION"
"412","Occurrence Cystic Dilatation Renal Tubule","Kidney dysfunction by decreased thyroid hormone","ABNORMAL RENAL TUBULE MORPHOLOGY"
"413","Occurrence Cytoplasmic Vacuolization Podocyte","Kidney dysfunction by decreased thyroid hormone","CYTOPLASMIC RIBOSOMAL PROTEINS"
"414","Decreased Renal Ability To Dilute Urine","Kidney dysfunction by decreased thyroid hormone","ABNORMALITY OF ADRENAL PHYSIOLOGY"
"415","Activation Keratinocytes","Covalent Protein binding leading to Skin Sensitisation","GO:0002534"
"416","Inhibition Phospholipase A","Phospholipase A2 (LPLA2) inhibitors leading to hepatotoxicity","GO:0004620"
"417","Damage Lipid Bilayer","Phospholipase A2 (LPLA2) inhibitors leading to hepatotoxicity","LIPID METABOLISM PATHWAY"
"418","Disturbance Lysosomal Function","Phospholipase A2 (LPLA2) inhibitors leading to hepatotoxicity","LYSOSOMAL TRANSPORT"
"419","Occurrence Cytoplasmic Vacuolization Hepatocyte","Phospholipase A2 (LPLA2) inhibitors leading to hepatotoxicity","SIGNALING OF HEPATOCYTE GROWTH FACTOR RECEPTOR"
"420","Occurrence Ballooning Degeneration Hepatocyte","Phospholipase A2 (LPLA2) inhibitors leading to hepatotoxicity","SIGNALING OF HEPATOCYTE GROWTH FACTOR RECEPTOR"
"421","Occurrence Cytoplasmic Vacuolization Bile Duct Cell","Phospholipase A2 (LPLA2) inhibitors leading to hepatotoxicity","UPPER MOTOR NEURON DYSFUNCTION"
"422","Occurrence Cytoplasmic Vacuolization Kupffer Cell","Phospholipase A2 (LPLA2) inhibitors leading to hepatotoxicity","UPPER MOTOR NEURON DYSFUNCTION"
"423","Induction Microvesicular Fat","Phospholipase A2 (LPLA2) inhibitors leading to hepatotoxicity","FAT MALABSORPTION"
"424","Formation Liver Fibrosis","Phospholipase A2 (LPLA2) inhibitors leading to hepatotoxicity","ABNORMAL LIVER MORPHOLOGY"
"425","Inhibition Urod","Aryl hydrocarbon receptor activation leading to uroporphyria","GO:0003824"
"426","Accumulation Highly Carboxylated Porphyrins","Aryl hydrocarbon receptor activation leading to uroporphyria","CTOME METABOLISM OF PORPHYRINS"
"427","Changes/Inhibition Cellular Homeostasis And Apoptosis","Sustained AhR Activation leading to Rodent Liver Tumours","GO:0006915"
"428","Alterations Cellular Proliferation / Hyperplasia","Sustained AhR Activation leading to Rodent Liver Tumours","GO:0008283"
"429","Formation Hepatocellular And Bile Duct Tumors","Sustained AhR Activation leading to Rodent Liver Tumours","HEPATOCELLULAR CARCINOMA"
"430","Decreased Pparalpha Transactivation Of Gene Expression","Antagonist binding to PPARÎ± leading to body-weight loss","GO:0035624"
"431","Decreased Mitochondrial Fatty Acid Beta Oxidation","Glucocorticoid Receptor activation leading to hepatic steatosis","GO:0006635"
"432","Decreased Ketogenesis Production Of Ketone Bodies","Antagonist binding to PPARÎ± leading to body-weight loss","CTOME SYNTHESIS OF KETONE BODIES"
"433","Not Increased Circulating Ketone Bodies","Antagonist binding to PPARÎ± leading to body-weight loss","SYNTHESIS AND DEGRADATION OF KETONE BODIES"
"434","Increased Catabolism Of Muscle Protein","Antagonist binding to PPARÎ± leading to body-weight loss","GO:0030163"
"435","Decreased Body Weight","Antagonist binding to PPARÎ± leading to body-weight loss","DECREASED BODY WEIGHT"
"436","Decrease Intracellular Ph","Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors","REGULATION OF PH"
"437","Increase Tissue Degeneration Necrosis & Atrophy","Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors","GO:0070265"
"438","Increase Respiratory Or Squamous Metaplasia","Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors","SQUAMOUS CELL CARCINOMA"
"439","Release Cytokine","Cholestatic Liver Injury induced by Inhibition of the Bile Salt Export Pump (ABCB11)","GO:0050663"
"440","Increase Site Of Contact Nasal Tumors","Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors","ABNORMAL NASAL MORPHOLOGY"
"441","Binding Of Agonist Ionotropic Glutamate Receptors","Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.","GO:0004970"
"442","Increase Mutations In Critical Genes","Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors","SOMATIC MUTATION"
"443","Inhibition Srebp1c","NFE2L2/FXR activation leading to hepatic steatosis","STEROL REGULATORY ELEMENTBINDING PROTEINS SREBP SIGNALLIN"
"444","Increase Cancer","Alkylation of DNA leading to cancer 2","BLADDER CANCER"
"445","Inhibition Nadh-Ubiquinone Oxidoreductase Complex I","Inhibition of the mitochondrial complex I of nigro-striatal neurons leads to parkinsonian motor deficits","GO:0008137"
"446","Binding Of Inhibitor Nadh-Ubiquinone Oxidoreductase Complex I","Inhibition of the mitochondrial complex I of nigro-striatal neurons leads to parkinsonian motor deficits","GO:0006120"
"447","Impaired Proteostasis","Inhibition of the mitochondrial complex I of nigro-striatal neurons leads to parkinsonian motor deficits","REGULATION OF PROTEOLYSIS"
"448","Synthesis De Novo Fa","LXR activation leading to hepatic steatosis","GO:0006633"
"449","Disruption Lysosome","Receptor mediated endocytosis and lysosomal overload leading to kidney toxicity","GO:1903008"
"450","Infiltration Inflammatory Cells","Activation of reactive oxygen species leading the atherosclerosis","GO:0006954"
"451","Inflammation Liver","Dysregulated prolonged Toll Like Receptor 9 (TLR9) activation leading to Multi Organ Failure involving Acute Respiratory Distress Syndrome (ARDS)","ABNORMAL LIVER MORPHOLOGY"
"452","Oxidation Glutathione","Binding of electrophilic chemicals to SH(thiol)-group of proteins and /or to seleno-proteins involved in protection against oxidative stress leads to chronic kidney disease","GO:0016209"
"453","Depletion Nitric Oxide","Peptide Oxidation Leading to Hypertension","GO:0006809"
"454","Decrease Tetrahydrobiopterin","Peptide Oxidation Leading to Hypertension","GO:0009058"
"455","Decrease Gtpch-1","Peptide Oxidation Leading to Hypertension","GO:1903009"
"456","Impaired Vasodilation","Peptide Oxidation Leading to Hypertension","GO:0042311"
"457","Activation Egfr","EGFR Activation Leading to Decreased Lung Function","CTOME SIGNALING BY EGFR"
"458","Dimerization Ahr/Arnt","Aryl hydrocarbon receptor activation leading to early life stage mortality, via reduced VEGF","GO:0046983"
"459","Reduced Dimerization Arnt/Hif1-Alpha","Aryl hydrocarbon receptor activation leading to early life stage mortality, via reduced VEGF","GO:0046983"
"460","Reduced Production Vegf","Aryl hydrocarbon receptor activation leading to early life stage mortality, via reduced VEGF","G VEGF SIGNALING PATHWAY"
"461","Increase Vascular Resistance","Peptide Oxidation Leading to Hypertension","INCREASED PULMONARY VASCULAR RESISTANCE"
"462","Increase Mucin Production","EGFR Activation Leading to Decreased Lung Function","GO:0046903"
"463","Alkylation Dna","Alkylation of DNA in male pre-meiotic germ cells leading to heritable mutations","GO:0006305"
"464","Decrease Akt/Enos Activity","Peptide Oxidation Leading to Hypertension","GO:0003824"
"465","Reduction Abdominal Muscle Contraction","Ecdysone receptor agonism leading to incomplete ecdysis associated mortality","GO:0006936"
"466","Binding Of Antagonist Ppar Alpha","Antagonist binding to PPARÎ± leading to body-weight loss","GO:0048019"
